Supply of Mepolizumab (Nucala(r))

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000525420-2018-02-01T00:00:00Z",
    "date": "2018-02-01T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000525420",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-4",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "email": "stuart.gillespie@nhs.net",
                "telephone": "+44 1698794400",
                "url": "http://"
            },
            "roles": [
                "buyer",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        },
        {
            "id": "org-55",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "email": "stuart.gillespie@nhs.net",
                "telephone": "+44 1698794400",
                "url": "http://"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
        "id": "org-55"
    },
    "tender": {
        "id": "NP93717",
        "title": "Supply of Mepolizumab (Nucala(r))",
        "description": "The supply of Mepolizumab (Nucala(r)) to NHSScotland",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationale": "The medicine awarded to this framework agreement is, and will continue to be, protected by patent for the duration of the framework agreement.",
        "mainProcurementCategory": "goods",
        "documents": [
            {
                "id": "JAN306368",
                "documentType": "awardNotice",
                "title": "Supply of Mepolizumab (Nucala(r))",
                "description": "The supply of Mepolizumab (Nucala(r)) to NHSScotland",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN306368",
                "format": "text/html"
            },
            {
                "id": "FEB308743",
                "documentType": "awardNotice",
                "title": "Supply of Mepolizumab (Nucala(r))",
                "description": "The supply of Mepolizumab (Nucala(r)) to NHSScotland",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB308743",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "This procurement is for the supply of Mepolizumab (Nucala(r)) to NHSScotland. The Authority has awarded a single-supplier framework agreement for the requirement.",
                "status": "complete",
                "hasOptions": false
            }
        ],
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_PROTECT_RIGHTS",
                "description": "The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights",
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
            }
        ],
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages."
    },
    "awards": [
        {
            "id": "NP93717",
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "NP93717",
            "awardID": "NP93717",
            "status": "active",
            "dateSigned": "2018-01-22T00:00:00Z"
        }
    ],
    "language": "EN",
    "description": "The total value in Section II.1.7 and V.2.4 refers to the full forty eight (48) month duration of the framework agreement. (SC Ref:528321)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000525420"
        },
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000525420"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice",
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2018/S 009-015887"
        }
    ]
}